Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inflammatory Mediators, Neural Tissue Injury Markers and the Markers of Oxidative Stress in the CSF of Patients Undergoing Spinal Anesthesia With Ropivacaine and Bupivacaine

NCT03293472 is registered in ClinicalTrials.gov with University of Rzeszow as lead sponsor.

NCT NCT03293472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03293472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inflammatory Mediators, Neural Tissue Injury Markers and the Markers of Oxidative Stress in the CSF of Patients Undergoing Spinal Anesthesia With Ropivacaine and Bupivacaine
Lead sponsor
University of Rzeszow
Phase
Phase 4
Overall status
Unknown status
Start date
December 1, 2017
Completion date
December 31, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaesthetic complication neurological, anesthesia; adverse effect, spinal and epidural